Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (321-330 of 527) with videos related to

Pageof 53
Sort By:
Journal of Gastroenterology and Hepatology|August 16, 2019
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agentsTyng-Yuan Jang, Ching-I Huang, Ming-Lun Yeh, et al.
The American Journal of Gastroenterology|May 29, 2007
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implicationJee-Fu Huang, Chia-Yen Dai, Shang-Jyh Hwang, et al.
The Kaohsiung Journal of Medical Sciences|October 16, 2016
Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core proteinShu-Chi Wang, Jeng-Fu Yang, Chao-Ling Wang, et al.
The Journal of Infectious Diseases|November 20, 2018
Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected PatientsMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 18, 2024
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitisChung-Feng Huang, Po-Cheng Liang, Chih-Wen Wang, et al.
The Kaohsiung Journal of Medical Sciences|July 14, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver DiseaseJee-Fu Huang, Chi-Yi Chen, Ming-Jong Bair, et al.
Clinical and Molecular Hepatology|December 15, 2020
Scaling up the in-hospital hepatitis C virus care cascade in TaiwanChung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2022
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patientsTakanori Ito, Vy H Nguyen, Taku Tanaka, et al.
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Ebiomedicine|December 22, 2016
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral TreatmentChung-Feng Huang, Cing-Yi Huang, Ming-Lun Yeh, et al.
Pageof 53

Showing results (321-330 of 527) with videos related to

Sort By:
Pageof 53
Journal of Gastroenterology and Hepatology|August 16, 2019
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agentsTyng-Yuan Jang, Ching-I Huang, Ming-Lun Yeh, et al.
The American Journal of Gastroenterology|May 29, 2007
Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implicationJee-Fu Huang, Chia-Yen Dai, Shang-Jyh Hwang, et al.
The Kaohsiung Journal of Medical Sciences|October 16, 2016
Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core proteinShu-Chi Wang, Jeng-Fu Yang, Chao-Ling Wang, et al.
The Journal of Infectious Diseases|November 20, 2018
Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected PatientsMing-Lun Yeh, Ching-I Huang, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 18, 2024
Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitisChung-Feng Huang, Po-Cheng Liang, Chih-Wen Wang, et al.
The Kaohsiung Journal of Medical Sciences|July 14, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver DiseaseJee-Fu Huang, Chi-Yi Chen, Ming-Jong Bair, et al.
Clinical and Molecular Hepatology|December 15, 2020
Scaling up the in-hospital hepatitis C virus care cascade in TaiwanChung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2022
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patientsTakanori Ito, Vy H Nguyen, Taku Tanaka, et al.
Hepatology International|December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
Ebiomedicine|December 22, 2016
Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral TreatmentChung-Feng Huang, Cing-Yi Huang, Ming-Lun Yeh, et al.
Pageof 53